Package Leaflet: Information for the User
Tremfya 100 mg solution for injection in pre-filled syringe
guselkumab
This medicine is subject to additional monitoring, which will allow for the quick identification of new safety information. You can help by reporting any side effects you may have. The last section of section 4 will tell you how to report side effects.
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Keep this leaflet, you may need to read it again.
Contents of the pack
Tremfya contains the active substance guselkumab, which is a type of protein called a monoclonal antibody.
This medicine works by blocking the activity of a protein called IL-23, which is found in higher amounts in people with psoriasis and psoriatic arthritis.
Plaque psoriasis
Tremfya is used to treat adults with moderate to severe plaque psoriasis, an inflammatory condition that affects the skin and nails.
Tremfya may improve skin and nail conditions and reduce symptoms such as scaling, shedding, exfoliation, itching, pain, and discomfort.
Psoriatic arthritis
Tremfya is used to treat a condition called psoriatic arthritis, an inflammatory disease of the joints, often accompanied by psoriasis. If you have psoriatic arthritis, you will first be given other medicines. If you do not respond well enough to these medicines, you will be given Tremfya to reduce the signs and symptoms of your disease. Tremfya can be used alone or with another medicine called methotrexate.
Using Tremfya for psoriatic arthritis will help you by reducing the signs and symptoms of the disease, slowing down the damage to the cartilage and bones of the joints, and improving your ability to perform normal daily activities.
Do not use Tremfya
If you have an active infection, including active tuberculosis.
Warnings and precautions
Talk to your doctor, pharmacist, or nurse before using Tremfya:
If you are not sure if any of the above conditions apply to you, talk to your doctor, pharmacist, or nurse before using Tremfya.
Following your doctor's instructions, before you receive Tremfya and when you are about to use it, you may need to have blood tests to check if you have elevated levels of liver enzymes. Increases in liver enzymes may be more frequent in patients who receive Tremfya every 4 weeks than in those who receive Tremfya every 8 weeks (see "How to use Tremfya" in section 3).
Monitoring for infections and allergic reactions
Tremfya has the potential to cause serious side effects, including allergic reactions and infections. You should monitor for signs of these conditions while you are receiving Tremfya.
Stop using Tremfya and consult your doctor or seek immediate medical attention if you notice any signs that may indicate a serious allergic reaction or infection.
Signs of infection may include fever or flu-like symptoms; muscle pain; cough; difficulty breathing; painful urination or urinating more frequently than usual; blood in the sputum; weight loss; diarrhea or stomach pain; hot, red, or painful skin, or sores on the body that are different from psoriasis lesions.
Serious allergic reactions have occurred with Tremfya, which may include the following symptoms: swelling of the face, lips, tongue, or throat; difficulty swallowing or breathing; and hives (see "Serious side effects" in section 4).
Children and adolescents
Tremfya is not recommended for use in children and adolescents under 18 years of age because there are no studies in this age group.
Other medicines and Tremfya
Talk to your doctor or pharmacist:
If you have been vaccinated recently or are about to be vaccinated. You should not receive certain types of vaccines (live vaccines) while using Tremfya.
Pregnancy and breastfeeding
Tell your doctor if you are pregnant, think you may be pregnant, or plan to become pregnant.
Driving and using machines
Tremfya is unlikely to affect your ability to drive or use machines.
Follow exactly the administration instructions of this medicine given by your doctor or nurse. If you are not sure, consult your doctor, nurse, or pharmacist.
How much Tremfya to use and for how long
Your doctor will decide how long you need to use Tremfya.
Plaque psoriasis
Psoriatic arthritis
At first, your doctor or nurse will inject Tremfya. However, you and your doctor may decide that you can inject Tremfya yourself, in which case you will receive proper training on how to inject Tremfya. Consult your doctor or nurse if you have any questions about administering the injections. It is important that you do not try to inject yourself until your doctor or nurse has taught you how to do it.
To learn how to use Tremfya, read the "Instructions for use" leaflet carefully before using it, which is attached to the packaging.
If you use more Tremfya than you should
If you have received more Tremfya than you should or the dose has been given before the scheduled time, tell your doctor.
If you forget to use Tremfya
If you have forgotten to inject a dose of Tremfya, tell your doctor.
If you stop using Tremfya
Do not stop using Tremfya without talking to your doctor first. If you stop treatment, your symptoms may come back.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Tell your doctor or seek immediate medical attention if you experience any of the following side effects:
Possible serious allergic reaction(may affect up to 1 in 100 people) - the signs may include:
Other side effects
The following side effects are all mild to moderate. If any of these side effects gets serious, talk to your doctor, pharmacist, or nurse immediately.
Some side effects are very common (may affect more than 1 in 10 people):
Some side effects are common (may affect up to 1 in 10 people):
Some side effects are uncommon (may affect up to 1 in 100 people):
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label of the syringe and on the carton after EXP. The expiry date is the last day of the month stated.
Store the pre-filled syringe in the outer packaging to protect it from light.
Store in a refrigerator (2°C–8°C). Do not freeze.
Do not shake.
Do not use this medicine if you notice it is cloudy or has an unusual color, or if it contains large particles. Before using the medicine, take the packaging out of the refrigerator and keep the pre-filled syringe inside until it reaches room temperature, waiting for 30 minutes.
This medicine is for single use only. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Tremfya
Appearance of Tremfya and Container Contents
Injectable solution (injection). Tremfya is a clear to light yellow solution. It is presented in a cardboard container containing a single-dose glass syringe
and as a multiple container containing 2 (2 containers of 1) single-dose prefilled syringes. Not all pack sizes may be marketed.
Marketing Authorization Holder
Janssen-Cilag International NV
Turnhoutseweg 30
B-2340 Beerse
Belgium
Manufacturer
Janssen Biologics B.V.
Einsteinweg 101
2333CB Leiden
Netherlands
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
België/Belgique/Belgien Janssen‑Cilag NV Tel/Tél: +32 14 64 94 11 | Lietuva UAB "JOHNSON & JOHNSON" Tel: +370 5 278 68 88 |
България „Джонсън & Джонсън“ ЕООД Тел: +359 2 489 94 00 | Luxembourg/Luxemburg Janssen‑Cilag NV Tél/Tel: +32 14 64 94 11 |
Ceská republika Janssen‑Cilag s.r.o. Tel.: +420 227 012 227 | Magyarország Janssen‑Cilag Kft. Tel.: +36 1 884 2858 |
Danmark Janssen‑Cilag A/S Tlf: +45 45 94 8282 | Malta AM MANGION LTD. Tel: +356 2397 6000 |
Deutschland Janssen‑Cilag GmbH Tel: +49 2137 955 955 | Nederland Janssen‑Cilag B.V. Tel: +31 76 711 1111 |
Eesti UAB "JOHNSON & JOHNSON" Eesti filiaal Tel: +372 617 7410 | Norge Janssen‑Cilag AS Tlf: +47 24 12 65 00 |
Ελλ?δα Janssen‑Cilag Φαρμακευτικ? Α.Ε.Β.Ε. Τηλ: +30 210 80 90 000 | Österreich Janssen‑Cilag Pharma GmbH Tel: +43 1 610 300 |
España Janssen‑Cilag, S.A. Tel: +34 91 722 81 00 | Polska Janssen‑Cilag Polska Sp. z o.o. Tel.: +48 22 237 60 00 |
France Janssen‑Cilag Tél: 0 800 25 50 75 / +33 1 55 00 40 03 | Portugal Janssen‑Cilag Farmacêutica, Lda. Tel: +351 214 368 600 |
Hrvatska Johnson & Johnson S.E. d.o.o. Tel: +385 1 6610 700 | România Johnson & Johnson România SRL Tel: +40 21 207 1800 |
Ireland Janssen Sciences Ireland UC Tel: +353 1 800 709 122 | Slovenija Johnson & Johnson d.o.o. Tel: +386 1 401 18 00 |
Ísland Janssen‑Cilag AB c/o Vistor hf. Sími: +354 535 7000 | Slovenská republika Johnson & Johnson, s.r.o. Tel: +421 232 408 400 |
Italia Janssen‑Cilag SpA Tel: 800.688.777/+39 02 2510 1 | Suomi/Finland Janssen‑Cilag Oy Puh/Tel: +358 207 531 300 |
Κ?προς Βαρν?βας Χατζηπαναγ?ς Λτδ Τηλ: +357 22 207 700 | Sverige Janssen‑Cilag AB Tel: +46 8 626 50 00 |
Latvija UAB "JOHNSON & JOHNSON" filiale Latvija Tel: +371 678 93561 | United Kingdom Janssen‑Cilag Ltd. Tel: +44 1 494 567 444 |
Date of the last revision of this leaflet: 02/2021
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu, and on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).
Instructions for Use
Tremfya
Prefilled Syringe

Important
If your doctor decides that you or a caregiver can administer the Tremfya injections at home, you must learn to prepare and inject Tremfya correctly with the prefilled syringe before attempting the injection.
Read these instructions for use before using the Tremfya prefilled syringe and each time you renew your prescription. There may be new information. This instruction guide does not replace the need to talk to your doctor about your disease or treatment. Also, read the package leaflet carefully before starting to inject yourself and consult any questions you have with your doctor or nurse.
The Tremfya prefilled syringe should be injected under the skin and not into a muscle or vein. After the injection, the needle will retract into the syringe body and lock into place.

Store in the refrigerator between 2 °C and 8 °C. Do notfreeze.
Keep Tremfya and all medicines out of the reach of children.
Do notshake the prefilled syringe at any time.
FOR SINGLE USE ONLY
The Prefilled Syringe at a Glance




Inspect the Carton
Remove the carton containing the prefilled syringe from the refrigerator.
Keep the prefilled syringe in the carton and place it on a flat surface at room temperature for at least 30 minutesbefore using it.
Do notheat it in any other way.
Check the Expiration Date (EXP)on the back of the carton.
Do notuse the medicine after the expiration date.
Do notinject the medicine if the carton perforations are broken.
Talk to your doctor or pharmacist to have the medicine prescribed again.

Choose the Injection Site
Choose from the following areas to administer the injection:
Do notuse the area within 5 cm of the navel.
Do notinject into painful, bruised, red, scaly, or hard skin.
Do notinject into areas with scars or stretch marks.

Clean the Injection Site
Wash your hands well with warm water and soap.
Clean the chosen injection site with an alcohol swab and let it dry.
Do nottouch, fan, or blow on the injection site after cleaning.

Inspect the Liquid
Remove the prefilled syringe from the carton.
Check the liquid in the viewing window. The liquid should be clear or light yellow and may contain tiny translucent or white particles. You may also see one or more air bubbles.
This is normal.
Do notinject if the liquid is cloudy or has an abnormal color, or contains large particles. If you are unsure, consult your doctor or pharmacist to have the medicine prescribed again.

Remove the Needle Cap
Hold the syringe by the body and remove the needle cap.
It is normal to see a drop of liquid.
Inject within 5 minutes of removing the needle cap.
Do notreplace the needle cap because the needle could be damaged.
Do nottouch the needle or let it touch any surface.
Do notuse the Tremfya prefilled syringe if it is dropped. Consult your doctor or pharmacist to have the medicine prescribed again.

Place Fingers and Insert Needle
Place your thumb, index, and middle fingers directly below the finger flange, as indicated.
Do nottouch the plunger or the area above the finger flange because this could activate the needle safety device.
Use your other hand to pinch the skin at the injection site.
Place the syringe at a 45° angle to the skin.
It is important to pinch a sufficient amount of skin to inject under the skinand not into the muscle.
Insert the needle with a quick motion, like throwing a dart.

Release Pinch and Replace Hand
Use your free hand to grasp the syringe body.

Press the Plunger
Place the thumb of your other hand on the plunger and press it until it stops.

Release Plunger Pressure
The safety protector will cover the needle and lock it into place, removing it from the skin.

Dispose of the Used Syringe
Place the used syringe in a sharps container after use.
When the container is full, dispose of the material according to the instructions of your doctor or nurse.

Check the Injection Site
There may be a small amount of blood or liquid at the injection site.
Apply pressure to the skin with a cotton ball or gauze until the bleeding stops.
Do notrub the injection site.
If necessary, cover the injection site with a band-aid.
Your injection is complete!

Consult your doctor with any questions you may have. For additional help or to share your experience, see the contact information of your local representative in the package leaflet.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for TREMFYA 100 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE – subject to medical assessment and local rules.